Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman
Retrieved on:
Tuesday, January 30, 2024
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant milestones and developments that have shaped Huxley over the past year.
Key Points:
- TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant milestones and developments that have shaped Huxley over the past year.
- Sintalica has filed four provisional patents for proprietary psychedelic molecules with unique properties, improved stability and safety profiles, and enhanced bioavailability.
- Bruce Linton is a proven disruptive leader in Technology, Cannabis, and Global Wellness Industries.
- Bruce currently holds the role as chair of the advisory board of Red Light Holland Corp. (CSE:TRIP)
“As a Co-Founder and Chairman of Huxley, I’m excited to help steward this innovative company and make a profound impact on healthcare discoveries.” Bruce Linton, Co-Founder and Chairman.